Ken Sato

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 13

Top Topics

Combination Therapy

Hepatitis C Virus

Helicobacter Pylori

Top Venues

Hepatology research : the official journal of the Japan Society of Hepatology

Clinical journal of gastroenterology

Clinical case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Ken Sato, Takehiro Shimizu, Akira Watanabe, Ayako Yamazaki, Yuki Kanayama, Tatsuma Murakami, Norifumi Harimoto, Hideaki Yokoo, Ken Shirabe, Masashi Namikawa
Successful radical surgery for lymph node metastasis in a patient with hepatocellular carcinoma following atezolizumab plus bevacizumab combination therapy: a case report and literature review. Clinical journal of gastroenterology (2024)
Hideyuki Suzuki, Ken Sato, Jirou Takezawa, Shoji Yamada, Masashi Namikawa, Hiroaki Okamoto
Successful prolonged treatment with sofosbuvir/velpatasvir for a hepatitis C patient with decompensated cirrhosis and treatment failure after 12-week therapy. Clinical journal of gastroenterology (2023)
Ken Sato, Atsushi Naganuma, Tamon Nagashima, Yosuke Arai, Yuka Mikami, Yuka Nakajima, Yuki Kanayama, Tatsuma Murakami, Sanae Uehara, Daisuke Uehara, Yuichi Yamazaki, Takayo Murase, Takashi Nakamura, Masashi Namikawa
A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases. Biomedicines 11 (5) (2023)
Kazuya Maeda, Hajime Takikawa, Mitsuhiko Aiso, Kenji Tsuji, Tatehiro Kagawa, Masaaki Watanabe, Ken Sato, Shotaro Sakisaka, Yoichi Hiasa, Yoshiyuki Takei, Hiromasa Ohira, Etsuko Hashimoto, Minoru Ayada, Tadashi Ikegami, Noriaki Arakawa, Hiroyuki Kusuhara, Yoshiro Saito, Yuichi Sugiyama
Frequency of null genotypes of glutathione S-transferase M1 and T1 in Japanese patients with drug-induced liver injury. Hepatology research : the official journal of the Japan Society of Hepatology 52 (10) (2022)
Ken Sato, Yuichi Yamazaki, Yuki Kanayama, Daisuke Uehara, Hiroki Tojima, Takayoshi Suga, Satoru Kakizaki, Naondo Sohara, Norio Horiguchi, Masashi Namikawa
Adolescents with chronic hepatitis C might be good candidates for direct-acting antiviral therapy. Clinical case reports 10 (4) (2022)
Ryosuke Nakamura, Noriaki Arakawa, Yoichi Tanaka, Nahoko Uchiyama, Akihiro Sekine, Yoichi Mashimo, Keiji Tsuji, Tatehiro Kagawa, Ken Sato, Masaaki Watanabe, Mitsuhiko Aiso, Yoichi Hiasa, Yoshiyuki Takei, Hiromasa Ohira, Minoru Ayada, Eri Tsukagoshi, Keiko Maekawa, Masahiro Tohkin, Yoshiro Saito, Hajime Takikawa
Significant association between HLA-B*35:01 and onset of drug-induced liver injury caused by Kampo medicines in Japanese patients. Hepatology research : the official journal of the Japan Society of Hepatology (2022)
Ryosuke Nakamura, Noriaki Arakawa, Yoichi Tanaka, Nahoko Uchiyama, Akihiro Sekine, Yoichi Mashimo, Keiji Tsuji, Tatehiro Kagawa, Ken Sato, Masaaki Watanabe, Mitsuhiko Aiso, Yoichi Hiasa, Yoshiyuki Takei, Hiromasa Ohira, Minoru Ayada, Eri Tsukagoshi, Keiko Maekawa, Masahiro Tohkin, Yoshiro Saito, Hajime Takikawa
Significant association between HLA-B*35:01 and onset of drug-induced liver injury caused by Kampo medicines in Japanese. Hepatology research : the official journal of the Japan Society of Hepatology (2022)
Satoshi Takakusagi, Ken Sato, Kyoko Marubashi, Kazuko Kizawa, Takashi Kosone, Satoru Kakizaki, Hitoshi Takagi, Masashi Namikawa
Impact of M2BPGi on the Hepatocarcinogenesis after the Combination Therapy with Daclatasvir and Asunaprevir for Hepatitis C. Biomedicines 9 (6) (2021)
Ken Sato, Yuki Kanayama, Yuichi Yamazaki, Hiroki Tojima, Takayoshi Suga, Daisuke Uehara, Satoru Kakizaki, Kunio Yanagisawa, Toshio Uraoka, Hiroshi Ohnishi, Hiroaki Okamoto
Successful treatment of Japanese hemophilia patient co-infected with HIV and HCV genotype 4a by glecaprevir/pibrentasvir therapy. Clinical journal of gastroenterology 14 (6) (2021)
Yoshinari Takaoka, Kouichi Miura, Naoki Morimoto, Tadashi Ikegami, Satoru Kakizaki, Ken Sato, Takashi Ueno, Atsushi Naganuma, Takashi Kosone, Hirotaka Arai, Takeshi Hatanaka, Toshiyuki Tahara, Shigeo Tano, Takaaki Ohtake, Toshimitsu Murohisa, Masashi Namikawa, Takeharu Asano, Toshiro Kamoshida, Katsuhiko Horiuchi, Takeshi Nihei, Atsuko Soeda, Hidekazu Kurata, Takeshi Fujieda, Toshiya Ohtake, Yukimura Fukaya, Makoto Iijima, Shunji Watanabe, Norio Isoda, Hironori Yamamoto, null null
Real-world efficacy and safety of 12-week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection. Hepatology research : the official journal of the Japan Society of Hepatology 51 (1) (2020)
Hiroki Tojima, Satoru Kakizaki, Satoshi Takakusagi, Takashi Hoshino, Atsushi Naganuma, Tamon Nagashima, Masashi Namikawa, Takashi Ueno, Yasushi Shimada, Takeshi Hatanaka, Daichi Takizawa, Hirotaka Arai, Ken Sato, Hitoshi Takagi, Toshio Uraoka
Favorable outcome of retreatment by direct-acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failure. Hepatology research : the official journal of the Japan Society of Hepatology 50 (3) (2019)
Atsushi Naganuma, Ken Sato, Toru Fukuchi, Masashi Namikawa, Satoru Kakizaki, Toshio Uraoka, Hiroshi Ohnishi, Hiroaki Okamoto
Successful prolonged treatment of glecaprevir/pibrentasvir for chronic hepatitis C patient with treatment failure after 8-week therapy: a case report. Clinical journal of gastroenterology 12 (6) (2019)
Takeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima, Masashi Namikawa, Hiroki Tojima, Yasushi Shimada, Daichi Takizawa, Atsushi Naganuma, Hirotaka Arai, Ken Sato, Norifumi Harimoto, Ken Shirabe, Toshio Uraoka
Analyses of objective response rate, progression-free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study. Hepatology research : the official journal of the Japan Society of Hepatology 50 (3) (2019)
Toshihiko Sagawa, Ken Sato, Taku Tomizawa, Masafumi Mizuide, Hidetoshi Yasuoka, Yasuyuki Shimoyama, Shiko Kuribayashi, Satoru Kakizaki, Osamu Kawamura, Motoyasu Kusano, Masanobu Yamada
A prospective randomized controlled trial of AJG522 versus standard PEG+E as bowel preparation for colonoscopy. BioMed research international 2015 (2015)